Company: IPST
Filing Date: 2025-08-26
Form Type: S-1
Source: 0001213900-25-080839
Chunk: 19

Company: Heritage Distilling Holding Company, Inc.
Filing Date: 2025-08-26
Form: S-1
Chunk 19
---
”), we have filed registration statements under the Securities Act to register the resale by the ELOC Investor of up to 15,000,000 of the ELOC Shares that we may elect, in our sole discretion, to issue and sell to the ELOC Investor, from time to time under the ELOC Purchase Agreement. Unless earlier terminated, the ELOC Purchase Agreement will remain in effect until the earlier of: (i) the expiry of the 36 -monthperiod commencing on the Commencement Date (as defined in the ELOC Purchase Agreement), (ii) the date on which the Investor has purchased the Maximum Commitment Amount (the “Commitment Period”), or (iii) an earlier date mutually agreed upon by both us and the Investor in the future. Under the terms of the ELOC Purchase Agreement, the ELOC Investor may not purchase any ELOC Shares under the ELOC Purchase Agreement if such shares, when aggregated with all other shares then beneficially owned by the ELOC Investor and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule13d -3promulgated thereunder) would result in the ELOC Investor beneficially owning shares in excess of 4.99% of the number of our shares outstanding immediately after giving effect to the issuance of shares issuable pursuant to a Put Notice (as defined below). Through August25, 2025, we had sold an aggregate of 11,962,810shares of common stock to the ELOC Investor under the ELOC Purchase Agreement for which we received aggregate gross proceeds in the amount of $4,817,235. 8 Private Placement of Additional Shares of Series B Preferred Stock.Including the shares of Series B Preferred Stock sold to the ELOC Investor under the ELOC Purchase Agreement as discussed above, between February 21, 2025 and August25, 2025, we sold in a private placement to 15 accredited investors an aggregate of 756,854shares of Series B Preferred Stock, with certain investors receiving an aggregate of: warrants to purchase common stock at $0.01 per share; and 327,868 warrants to purchase common stock at $0.001 per share, for aggregate gross proceeds of $7,568,557, of which: $2,916,810 or 291,681shares was from cash investors; $4,092,567 or 409,256shares of Series B Preferred Stock was from